Chopper, I will speculate, and my speculation
Post# of 72440
Posted On: 05/02/2016 4:02:04 PM
Re: Chopper101 #21958
Chopper,
I will speculate, and my speculation is no more valid than anyone else's:
Jorgenson was at the end of his time-limited contract. He could have perhaps signed an extension, but PERHAPS he wanted too much money and PERHAPS he had taken the Brillicidin work as far as his expertise was good for. When he had designed the Ph 2a study of B for Polymedix, he set the dosage too high, which created the tingling side effects (which Menon subsequently corrected with lower dosages after CTIX bought the PYMX assets).
All I know is, absent a definitive statement from him or Leo or Menonor one of the secretaries at CTIX to the contrary, we can assume nothing more than that he has a major amount of CTIX stock and can - by having changed his trajectory when he left - profit far more by getting in on the ground floor of a startup.
With that in mind, I attempted unsuccessfully to track him down. This was not to satisfy my personal curiosity, altho I am curious, but instead to hook him up with another startup with which I have a personal (not financial) interest in helping.
Jorgenson has a golden reputation among startups and I can see why he would have had no problem finding a highly remunerative position with one.
I will speculate, and my speculation is no more valid than anyone else's:
Jorgenson was at the end of his time-limited contract. He could have perhaps signed an extension, but PERHAPS he wanted too much money and PERHAPS he had taken the Brillicidin work as far as his expertise was good for. When he had designed the Ph 2a study of B for Polymedix, he set the dosage too high, which created the tingling side effects (which Menon subsequently corrected with lower dosages after CTIX bought the PYMX assets).
All I know is, absent a definitive statement from him or Leo or Menonor one of the secretaries at CTIX to the contrary, we can assume nothing more than that he has a major amount of CTIX stock and can - by having changed his trajectory when he left - profit far more by getting in on the ground floor of a startup.
With that in mind, I attempted unsuccessfully to track him down. This was not to satisfy my personal curiosity, altho I am curious, but instead to hook him up with another startup with which I have a personal (not financial) interest in helping.
Jorgenson has a golden reputation among startups and I can see why he would have had no problem finding a highly remunerative position with one.
(3)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼